ArticleThoracic cancer2020

Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR-ANXA2, EGFR-RAD51, ATR and BRCA2 mutations: A case report.

Rui Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.